Fibroblastic niches in action: CCL19+ reticular cells drive anti-tumor immunity in lung cancer

In a groundbreaking study published in Cell , Onder and colleagues revealed the pivotal role of fibroblastic reticular cells (FRCs) in creating specialized niches, providing robust immune activation against non-small cell lung cancer (NSCLC), which paves the way for innovative therapeutic strategies. 1